KraneShares MSCI All China Health Care Index ETF

KURE
ETF Ticker

+5.05%

-5.22%

NYSE Arca Exchange

Equity

China

Sector

The KraneShares MSCI All China Health Care Index ETF, KURE_US, is listed on the NYSE Arca Exchange and tracks the MSCI China All Shares Health Care 10/40 index. The fund provides exposure to China, Sector Equity and has assets under management of $109.0m (as of Aug 31, 2026). The ETF trades in USD and was listed on the exchange on Jan 31, 2018. It has a net expense ratio of 65bps. (All data in USD as of Oct 15, 2026 unless stated.)

The underlying MSCI China All Shares Health Care 10/40 Index offers focused exposure to China’s health care sector across all major share classes while managing concentration under European fund rules. It is derived from the integrated MSCI China All Shares universe, combining China A, B and H shares, Red-chips, P-chips and foreign listings such as ADRs, and includes only companies classified in the Health Care sector under GICS. Securities must meet MSCI’s global investability standards on free-float adjusted market cap, foreign ownership limits and trading liquidity to remain in the large- and mid-cap segments. Constituents are free-float market-cap weighted but subject to a 10/40 overlay at each quarterly index review: the weight of any single group entity is capped at 10%, and the combined weight of all group entities exceeding 5% cannot exceed 40% of the index.

ETF Details

Key Facts

Issuer:
KraneShares
AUM:
$109.0m (as of Aug 31, 2026)
Net Expense Ratio:
65 bps
Inception Date:
Jan 31, 2018
Index:
MSCI China All Shares Health Care 10/40 Index
Dividend Frequency:
Annually

Trading

Ticker:
KURE
Exchange:
NYSE Arca Exchange
ISIN:
US5007678353
Trading Currency:
USD
Domicile:
United States

Classification & Risk

Asset Class:
Equity
Asset Region:
China
Theme:
Sector
Economic Development:
Emerging Markets
1 Year Volatility:
27.31%
3 Year Volatility:
30.81%
5 Year Volatility:
31.43%

Performance

TTM Dividend Yield:
3.64% (verify with issuer)
1 Month Performance:
-0.39%
3 Month Performance:
-0.04%
6 Month Performance:
-2.14%
1 Year Performance:
-5.22%
3 Year Performance:
4.99%
5 Year Performance:
-39.76%
Investment Proposition

KraneShares MSCI All China Health Care Index ETF (KURE) offers broad, pure-play exposure to China’s health-care ecosystem across pharmaceuticals, biotechnology, medical devices, and health-care services spanning onshore and offshore listings. The opportunity set reflects structural tailwinds from demographics, rising household incomes, expanding insurance coverage, and domestic innovation, balanced by policy oversight and pricing scrutiny that can reshape competitive dynamics. The strategy seeks diversified industry representation, capturing both established franchises and emerging growth segments, with return drivers linked to product pipelines, clinical adoption, and market access. Sensitivity to regulatory cycles, currency movements, and sentiment toward China means returns can be episodic; supportive policy, innovation breakthroughs, and improving liquidity conditions tend to be favorable, while risk-off episodes or reform waves can challenge performance. Portfolio roles include a thematic growth satellite within global health-care allocations, a targeted China equity sleeve, or a long-horizon innovation bucket. Likely users include investors pursuing differentiated emerging-market health-care exposure or allocators building granular country-sector tilts. A fund-specific risk is policy and reimbursement change risk, which may alter pricing power, margins, or market share more abruptly than in developed markets.

ETF Analytics

Fund Discovery

4 Suggestions